Table 4.

Response of patients treated with caplacizumab as initial treatment vs patients not treated with caplacizumab in terms of number of PEX, days of hospitalization, and days in the intensive care unit

	patients with iTTP treated with caplacizumab as initial treatment	patients with iTTP not treated with caplacizumab	P
No. of PEX
N	44	76	.017
Mean ± SD	12.39 ± 11.8	18.51 ± 19.05
Median (IQR)	8.5 (6-12.5)	14 (7-21.5)
Days of hospitalization
N	44	51	.001
Mean ± SD	14.68 ± 12.36	21.94 ± 14.42
Median (IQR)	12 (9-15)	19 (12-27)
Days in ICU
N	42	71	.796
Mean ± SD	2.31 ± 2.62	2.79 ± 3.51
Median (IQR)	2 (0-4)	2 (0-4)

ICU, intensive care unit; SD, standard deviation.